Delivery Order SPE2DB25D7060-SPE2DB25FXSRS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials each) at a ceiling value of $1,310.92. This firm fixed price delivery order is non-set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with completion expected by August 6, 2025. The contract represents a routine pharmaceutical procurement under the Defense Logistics Agency's medical supply chain...
- The Defense Logistics Agency awarded a $2,138.48 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials). This firm fixed-price, non-set-aside contract is scheduled for completion by September 5, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a routine pharmaceutical procurement under the company's existing relationship with the federal government's medical...
- The Defense Logistics Agency awarded a $1,342.88 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal conjugate vaccine. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitively awarded procurement. This...
- The Defense Logistics Agency awarded a $2,927.28 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo (1 vial A-C-Y-W-135-DIP, 0.5mL), a meningococcal vaccine product. The contract represents a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for Menveo A-C-Y-W Kit (2 Vials) with a ceiling value of $1,342.88. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX valued at $999,999,999.00 through December 2026), was competitively awarded with no set-aside designation. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.70 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials). This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a non-competitive award, indicating the product was procured through an existing contract vehicle rather than a new...
- This delivery order, awarded August 18, 2025, authorizes AmerisourceBergen Drug Corp to supply Menveo A-C-Y-W vaccine kits (two-vial configuration) to the Defense Logistics Agency's Medical Supply Chain, a Defense Department medical procurement function. The contract carries a ceiling value of $6,783.84 with firm fixed pricing and is scheduled for completion by August 19, 2025. The award was made through open competition with no set-aside designation, and the place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $7,087.92 to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,495.69 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Menveo vaccine (1 vial A-C-Y-W-135-DIP 0.5ML), with completion scheduled for June 20, 2025. This competitive award carries no set-aside designation and utilizes firm fixed pricing under a delivery order contract type. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine products, with a ceiling value of $119,112.76. This firm fixed-price delivery order is scheduled for completion by August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded on a competitive basis with no set-aside designation, reflecting the...
- SPE2DB25D7060Indefinite Delivery Contract
- SPE2DB25D7060-SPE2DB25FXSRSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials) with a ceiling value of $1,342.88. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a routine pharmaceutical procurement supporting the federal medical supply chain. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally. The Menveo vaccine delivery exemplifies the company's role as a critical vendor for the Defense Health Agency and other federal healthcare systems, fulfilling specialty pharmaceutical needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/13/25 |